Jenna D. Goldberg
- Hematology top 2%
- Multiple Myeloma Research and Treatments 16
- Hematopoietic Stem Cell Transplantation 11
- Acute Myeloid Leukemia Research 3
- Oncology top 10%
- CAR-T cell therapy research 8
- Peptidase Inhibition and Analysis 3
-
- Monoclonal and Polyclonal Antibodies Research 12
-
- Acute Lymphoblastic Leukemia research 4
-
- Protein Degradation and Inhibitors 3
- Co-authors
- María‐Victoria MateosNiels W.C.J. van de DonkDavid A. JacobsohnGeorgia B. VogelsangSuzette GirgisAmrita KrishnanRaluca VeronaBrandi Hilder
- Partner nations
- United StatesSpainNetherlands
In The Last Decade
Jenna D. Goldberg
27 papers receiving 629 citations
Peers
Comparison fields: 5 of 46
- Hematology 513
- Oncology 366
- Radiology, Nuclear Medicine and Imaging 188
- Transplantation 18
- Immunology 131
Countries citing papers authored by Jenna D. Goldberg
This map shows the geographic impact of Jenna D. Goldberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jenna D. Goldberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jenna D. Goldberg more than expected).
Fields of papers citing papers by Jenna D. Goldberg
This network shows the impact of papers produced by Jenna D. Goldberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jenna D. Goldberg. The network helps show where Jenna D. Goldberg may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jenna D. Goldberg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 19 | |
| 2 | 2022 | 7 | |
| 3 | 2022 | 30 | |
| 4 | 2022 | 10 | |
| 5 | 2022 | 45 | |
| 6 | 2021 | 40 | |
| 7 | 2021 | 1 | |
| 8 | 2021 | 20 | |
| 9 | 2020 | 48 | |
| 10 | 2020 | 1 | |
| 11 | 2015 | 36 | |
| 12 | 2014 | 14 | |
| 13 | 2013 | 26 | |
| 14 | 2013 | 48 | |
| 15 | 2013 | 36 | |
| 16 | 2013 | 7 | |
| 17 | 2013 | 4 | |
| 18 | 2012 | 1 | |
| 19 | 2005 | 33 | |
| 20 | 2003 | 31 |
About Jenna D. Goldberg
Jenna D. Goldberg is a scholar working on Hematology, Radiology, Nuclear Medicine and Imaging and Oncology, having authored 27 papers that have together received 638 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (16 papers), Monoclonal and Polyclonal Antibodies Research (12 papers), Hematopoietic Stem Cell Transplantation (11 papers), CAR-T cell therapy research (8 papers), Acute Lymphoblastic Leukemia research (4 papers), Acute Myeloid Leukemia Research (3 papers), Peptidase Inhibition and Analysis (3 papers) and Protein Degradation and Inhibitors (3 papers). The work is most often cited by research in Hematology (513 citations), Oncology (366 citations) and Radiology, Nuclear Medicine and Imaging (188 citations). Jenna D. Goldberg has collaborated with scholars based in United States, Spain and Netherlands. Frequent co-authors include María‐Victoria Mateos, Niels W.C.J. van de Donk, David A. Jacobsohn, Georgia B. Vogelsang, Suzette Girgis, Amrita Krishnan, Raluca Verona, Brandi Hilder, Sergio Giralt and Ajai Chari. Their work appears in journals such as Journal of Clinical Oncology, Blood and Arthritis & Rheumatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.